Global Celecoxib Market Growth 2020-2025


Sep, 2020 | Report ID: 146614 | 135 | Pharmaceuticals and Healthcare

According to this study, over the next five years the Celecoxib market will register a 8.7%% CAGR in terms of revenue, the global market size will reach $ 1548.5 million by 2025, from $ 1110.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Celecoxib business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Celecoxib market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Celecoxib, covering the supply chain analysis, impact assessment to the Celecoxib market size growth rate in several scenarios, and the measures to be undertaken by Celecoxib companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

50mg

100mg

200mg

400mg

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Rheumatoid arthritis

osteoarthritis

Acute pain

Musculoskeletal pain

Other diseases

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Pfizer Inc

Teva

Apotex

Lupin

Mylan

Hengrui Medicine

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Celecoxib consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Celecoxib market by identifying its various subsegments.

Focuses on the key global Celecoxib manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Celecoxib with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Celecoxib submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Celecoxib Consumption 2015-2025

2.1.2 Celecoxib Consumption CAGR by Region

2.2 Celecoxib Segment by Type

2.2.1 50mg

2.2.2 100mg

2.2.3 200mg

2.2.4 400mg

2.3 Celecoxib Consumption by Type

2.3.1 Global Celecoxib Consumption Market Share by Type (2015-2020)

2.3.2 Global Celecoxib Revenue and Market Share by Type (2015-2020)

2.3.3 Global Celecoxib Sale Price by Type (2015-2020)

2.4 Celecoxib Segment by Application

2.4.1 Rheumatoid arthritis

2.4.2 osteoarthritis

2.4.3 Acute pain

2.4.4 Musculoskeletal pain

2.4.5 Other diseases

2.5 Celecoxib Consumption by Application

2.5.1 Global Celecoxib Consumption Market Share by Type (2015-2020)

2.5.2 Global Celecoxib Value and Market Share by Type (2015-2020)

2.5.3 Global Celecoxib Sale Price by Type (2015-2020)

3 Global Celecoxib by Company

3.1 Global Celecoxib Sales Market Share by Company

3.1.1 Global Celecoxib Sales by Company (2018-2020)

3.1.2 Global Celecoxib Sales Market Share by Company (2018-2020)

3.2 Global Celecoxib Revenue Market Share by Company

3.2.1 Global Celecoxib Revenue by Company (2018-2020)

3.2.2 Global Celecoxib Revenue Market Share by Company (2018-2020)

3.3 Global Celecoxib Sale Price by Company

3.4 Global Celecoxib Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Celecoxib Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Celecoxib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Celecoxib by Regions

4.1 Celecoxib by Regions

4.2 Americas Celecoxib Consumption Growth

4.3 APAC Celecoxib Consumption Growth

4.4 Europe Celecoxib Consumption Growth

4.5 Middle East & Africa Celecoxib Consumption Growth

5 Americas

5.1 Americas Celecoxib Consumption by Countries

5.1.1 Americas Celecoxib Consumption by Countries (2015-2020)

5.1.2 Americas Celecoxib Value by Countries (2015-2020)

5.2 Americas Celecoxib Consumption by Type

5.3 Americas Celecoxib Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Celecoxib Consumption by Regions

6.1.1 APAC Celecoxib Consumption by Regions (2015-2020)

6.1.2 APAC Celecoxib Value by Regions (2015-2020)

6.2 APAC Celecoxib Consumption by Type

6.3 APAC Celecoxib Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Celecoxib by Countries

7.1.1 Europe Celecoxib Consumption by Countries (2015-2020)

7.1.2 Europe Celecoxib Value by Countries (2015-2020)

7.2 Europe Celecoxib Consumption by Type

7.3 Europe Celecoxib Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Celecoxib by Countries

8.1.1 Middle East & Africa Celecoxib Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Celecoxib Value by Countries (2015-2020)

8.2 Middle East & Africa Celecoxib Consumption by Type

8.3 Middle East & Africa Celecoxib Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Celecoxib Distributors

10.3 Celecoxib Customer

11 Global Celecoxib Market Forecast

11.1 Global Celecoxib Consumption Forecast (2021-2025)

11.2 Global Celecoxib Forecast by Regions

11.2.1 Global Celecoxib Forecast by Regions (2021-2025)

11.2.2 Global Celecoxib Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Celecoxib Forecast by Type

11.8 Global Celecoxib Forecast by Application

12 Key Players Analysis

12.1 Pfizer Inc

12.1.1 Company Information

12.1.2 Celecoxib Product Offered

12.1.3 Pfizer Inc Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 Pfizer Inc Latest Developments

12.2 Teva

12.2.1 Company Information

12.2.2 Celecoxib Product Offered

12.2.3 Teva Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Teva Latest Developments

12.3 Apotex

12.3.1 Company Information

12.3.2 Celecoxib Product Offered

12.3.3 Apotex Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Apotex Latest Developments

12.4 Lupin

12.4.1 Company Information

12.4.2 Celecoxib Product Offered

12.4.3 Lupin Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Lupin Latest Developments

12.5 Mylan

12.5.1 Company Information

12.5.2 Celecoxib Product Offered

12.5.3 Mylan Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Mylan Latest Developments

12.6 Hengrui Medicine

12.6.1 Company Information

12.6.2 Celecoxib Product Offered

12.6.3 Hengrui Medicine Celecoxib Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Hengrui Medicine Latest Developments

...

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Celecoxib Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of 50mg

Table 5. Major Players of 100mg

Table 6. Major Players of 200mg

Table 7. Major Players of 400mg

Table 8. Global Consumption Sales by Type (2015-2020)

Table 9. Global Celecoxib Consumption Market Share by Type (2015-2020)

Table 10. Global Celecoxib Revenue by Type (2015-2020) ($ million)

Table 11. Global Celecoxib Value Market Share by Type (2015-2020) ($ Millions)

Table 12. Global Celecoxib Sale Price by Type (2015-2020)

Table 13. Global Consumption Sales by Application (2015-2020)

Table 14. Global Celecoxib Consumption Market Share by Application (2015-2020)

Table 15. Global Celecoxib Value by Application (2015-2020)

Table 16. Global Celecoxib Value Market Share by Application (2015-2020)

Table 17. Global Celecoxib Sale Price by Application (2015-2020)

Table 18. Global Celecoxib Sales by Company (2017-2019) (K Units)

Table 19. Global Celecoxib Sales Market Share by Company (2017-2019)

Table 20. Global Celecoxib Revenue by Company (2017-2019) ($ Millions)

Table 21. Global Celecoxib Revenue Market Share by Company (2017-2019)

Table 22. Global Celecoxib Sale Price by Company (2017-2019)

Table 23. Global Celecoxib Manufacturing Base Distribution and Sales Area by Manufacturers

Table 24. Players Celecoxib Products Offered

Table 25. Celecoxib Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 26. Global Celecoxib Consumption by Regions 2015-2020 (K Units)

Table 27. Global Celecoxib Consumption Market Share by Regions 2015-2020

Table 28. Global Celecoxib Value by Regions 2015-2020 ($ Millions)

Table 29. Global Celecoxib Value Market Share by Regions 2015-2020

Table 30. Americas Celecoxib Consumption by Countries (2015-2020) (K Units)

Table 31. Americas Celecoxib Consumption Market Share by Countries (2015-2020)

Table 32. Americas Celecoxib Value by Countries (2015-2020) ($ Millions)

Table 33. Americas Celecoxib Value Market Share by Countries (2015-2020)

Table 34. Americas Celecoxib Consumption by Type (2015-2020) (K Units)

Table 35. Americas Celecoxib Consumption Market Share by Type (2015-2020)

Table 36. Americas Celecoxib Consumption by Application (2015-2020) (K Units)

Table 37. Americas Celecoxib Consumption Market Share by Application (2015-2020)

Table 38. APAC Celecoxib Consumption by Countries (2015-2020) (K Units)

Table 39. APAC Celecoxib Consumption Market Share by Countries (2015-2020)

Table 40. APAC Celecoxib Value by Regions (2015-2020) ($ Millions)

Table 41. APAC Celecoxib Value Market Share by Regions (2015-2020)

Table 42. APAC Celecoxib Consumption by Type (2015-2020) (K Units)

Table 43. APAC Celecoxib Consumption Market Share by Type (2015-2020)

Table 44. APAC Celecoxib Consumption by Application (2015-2020) (K Units)

Table 45. APAC Celecoxib Consumption Market Share by Application (2015-2020)

Table 46. Europe Celecoxib Consumption by Countries (2015-2020) (K Units)

Table 47. Europe Celecoxib Consumption Market Share by Countries (2015-2020)

Table 48. Europe Celecoxib Value by Countries (2015-2020) ($ Millions)

Table 49. Europe Celecoxib Value Market Share by Countries (2015-2020)

Table 50. Europe Celecoxib Consumption by Type (2015-2020) (K Units)

Table 51. Europe Celecoxib Consumption Market Share by Type (2015-2020)

Table 52. Europe Celecoxib Consumption by Application (2015-2020) (K Units)

Table 53. Europe Celecoxib Consumption Market Share by Application (2015-2020)

Table 54. Middle East & Africa Celecoxib Consumption by Countries (2015-2020) (K Units)

Table 55. Middle East & Africa Celecoxib Consumption Market Share by Countries (2015-2020)

Table 56. Middle East & Africa Celecoxib Value by Countries (2015-2020) ($ Millions)

Table 57. Middle East & Africa Celecoxib Value Market Share by Countries (2015-2020)

Table 58. Middle East & Africa Celecoxib Consumption by Type (2015-2020) (K Units)

Table 59. Middle East & Africa Celecoxib Consumption Market Share by Type (2015-2020)

Table 60. Middle East & Africa Celecoxib Consumption by Application (2015-2020) (K Units)

Table 61. Middle East & Africa Celecoxib Consumption Market Share by Application (2015-2020)

Table 62. Celecoxib Distributors List

Table 63. Celecoxib Customer List

Table 64. Global Celecoxib Consumption Forecast by Countries (2021-2025) (K Units)

Table 65. Global Celecoxib Consumption Market Forecast by Regions

Table 66. Global Celecoxib Value Forecast by Countries (2021-2025) ($ Millions)

Table 67. Global Celecoxib Value Market Share Forecast by Regions

Table 68. Global Celecoxib Consumption Forecast by Type (2021-2025) (K Units)

Table 69. Global Celecoxib Consumption Market Share Forecast by Type (2021-2025)

Table 70. Global Celecoxib Value Forecast by Type (2021-2025) ($ Millions)

Table 71. Global Celecoxib Value Market Share Forecast by Type (2021-2025)

Table 72. Global Celecoxib Consumption Forecast by Application (2021-2025) (K Units)

Table 73. Global Celecoxib Consumption Market Share Forecast by Application (2021-2025)

Table 74. Global Celecoxib Value Forecast by Application (2021-2025) ($ Millions)

Table 75. Global Celecoxib Value Market Share Forecast by Application (2021-2025)

Table 76. Pfizer Inc Product Offered

Table 77. Pfizer Inc Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 78. Pfizer Inc Main Business

Table 79. Pfizer Inc Latest Developments

Table 80. Pfizer Inc Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors

Table 81. Teva Product Offered

Table 82. Teva Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 83. Teva Main Business

Table 84. Teva Latest Developments

Table 85. Teva Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors

Table 86. Apotex Product Offered

Table 87. Apotex Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 88. Apotex Main Business

Table 89. Apotex Latest Developments

Table 90. Apotex Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors

Table 91. Lupin Product Offered

Table 92. Lupin Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 93. Lupin Main Business

Table 94. Lupin Latest Developments

Table 95. Lupin Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors

Table 96. Mylan Product Offered

Table 97. Mylan Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 98. Mylan Main Business

Table 99. Mylan Latest Developments

Table 100. Mylan Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors

Table 101. Hengrui Medicine Product Offered

Table 102. Hengrui Medicine Celecoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)

Table 103. Hengrui Medicine Main Business

Table 104. Hengrui Medicine Latest Developments

Table 105. Hengrui Medicine Basic Information, Company Total Revenue (in $ million), Celecoxib Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Celecoxib

Figure 2. Celecoxib Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Celecoxib Consumption Growth Rate 2015-2025 (K Units)

Figure 5. Global Celecoxib Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of 50mg

Figure 7. Product Picture of 100mg

Figure 8. Product Picture of 200mg

Figure 9. Product Picture of 400mg

Figure 10. Global Celecoxib Consumption Market Share by Type (2015-2020)

Figure 11. Global Celecoxib Value Market Share by Type (2015-2020)

Figure 12. Celecoxib Consumed in Rheumatoid arthritis

Figure 13. Global Celecoxib Market: Rheumatoid arthritis (2015-2020) (K Units)

Figure 14. Global Celecoxib Market: Rheumatoid arthritis (2015-2020) ($ Millions)

Figure 15. Celecoxib Consumed in osteoarthritis

Figure 16. Global Celecoxib Market: osteoarthritis (2015-2020) (K Units)

Figure 17. Global Celecoxib Market: osteoarthritis (2015-2020) ($ Millions)

Figure 18. Celecoxib Consumed in Acute pain

Figure 19. Global Celecoxib Market: Acute pain (2015-2020) (K Units)

Figure 20. Global Celecoxib Market: Acute pain (2015-2020) ($ Millions)

Figure 21. Celecoxib Consumed in Musculoskeletal pain

Figure 22. Global Celecoxib Market: Musculoskeletal pain (2015-2020) (K Units)

Figure 23. Global Celecoxib Market: Musculoskeletal pain (2015-2020) ($ Millions)

Figure 24. Celecoxib Consumed in Other diseases

Figure 25. Global Celecoxib Market: Other diseases (2015-2020) (K Units)

Figure 26. Global Celecoxib Market: Other diseases (2015-2020) ($ Millions)

Figure 27. Global Celecoxib Consumption Market Share by Application (2015-2020)

Figure 28. Global Celecoxib Value Market Share by Application (2015-2020)

Figure 29. Global Celecoxib Sales Market Share by Company in 2017

Figure 30. Global Celecoxib Sales Market Share by Company in 2019

Figure 31. Global Celecoxib Revenue Market Share by Company in 2017

Figure 32. Global Celecoxib Revenue Market Share by Company in 2019

Figure 33. Global Celecoxib Sale Price by Company in 2019

Figure 34. Global Celecoxib Consumption Market Share by Regions 2015-2020

Figure 35. Global Celecoxib Value Market Share by Regions 2015-2020

Figure 36. Americas Celecoxib Consumption 2015-2020 (K Units)

Figure 37. Americas Celecoxib Value 2015-2020 ($ Millions)

Figure 38. APAC Celecoxib Consumption 2015-2020 (K Units)

Figure 39. APAC Celecoxib Value 2015-2020 ($ Millions)

Figure 40. Europe Celecoxib Consumption 2015-2020 (K Units)

Figure 41. Europe Celecoxib Value 2015-2020 ($ Millions)

Figure 42. Middle East & Africa Celecoxib Consumption 2015-2020 (K Units)

Figure 43. Middle East & Africa Celecoxib Value 2015-2020 ($ Millions)

Figure 44. Americas Celecoxib Consumption Market Share by Countries in 2019

Figure 45. Americas Celecoxib Value Market Share by Countries in 2019

Figure 46. Americas Celecoxib Consumption Market Share by Type in 2019

Figure 47. Americas Celecoxib Consumption Market Share by Application in 2019

Figure 48. United States Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 49. United States Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 50. Canada Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 51. Canada Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 52. Mexico Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 53. Mexico Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 54. APAC Celecoxib Consumption Market Share by Countries in 2019

Figure 55. APAC Celecoxib Value Market Share by Regions in 2019

Figure 56. APAC Celecoxib Consumption Market Share by Type in 2019

Figure 57. APAC Celecoxib Consumption Market Share by Application in 2019

Figure 58. China Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 59. China Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 60. Japan Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 61. Japan Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 62. Korea Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 63. Korea Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 64. Southeast Asia Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 65. Southeast Asia Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 66. India Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 67. India Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 68. Australia Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 69. Australia Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 70. Europe Celecoxib Consumption Market Share by Countries in 2019

Figure 71. Europe Celecoxib Value Market Share by Countries in 2019

Figure 72. Europe Celecoxib Consumption Market Share by Type in 2019

Figure 73. Europe Celecoxib Consumption Market Share by Application in 2019

Figure 74. Germany Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 75. Germany Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 76. France Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 77. France Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 78. UK Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 79. UK Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 80. Italy Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 81. Italy Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 82. Russia Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 83. Russia Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 84. Middle East & Africa Celecoxib Consumption Market Share by Countries in 2019

Figure 85. Middle East & Africa Celecoxib Value Market Share by Countries in 2019

Figure 86. Middle East & Africa Celecoxib Consumption Market Share by Type in 2019

Figure 87. Middle East & Africa Celecoxib Consumption Market Share by Application in 2019

Figure 88. Egypt Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 89. Egypt Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 90. South Africa Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 91. South Africa Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 92. Israel Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 93. Israel Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 94. Turkey Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 95. Turkey Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 96. GCC Countries Celecoxib Consumption Growth 2015-2020 (K Units)

Figure 97. GCC Countries Celecoxib Value Growth 2015-2020 ($ Millions)

Figure 98. Global Celecoxib Consumption Growth Rate Forecast (2021-2025) (K Units)

Figure 99. Global Celecoxib Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 100. Americas Celecoxib Consumption 2021-2025 (K Units)

Figure 101. Americas Celecoxib Value 2021-2025 ($ Millions)

Figure 102. APAC Celecoxib Consumption 2021-2025 (K Units)

Figure 103. APAC Celecoxib Value 2021-2025 ($ Millions)

Figure 104. Europe Celecoxib Consumption 2021-2025 (K Units)

Figure 105. Europe Celecoxib Value 2021-2025 ($ Millions)

Figure 106. Middle East & Africa Celecoxib Consumption 2021-2025 (K Units)

Figure 107. Middle East & Africa Celecoxib Value 2021-2025 ($ Millions)

Figure 108. United States Celecoxib Consumption 2021-2025 (K Units)

Figure 109. United States Celecoxib Value 2021-2025 ($ Millions)

Figure 110. Canada Celecoxib Consumption 2021-2025 (K Units)

Figure 111. Canada Celecoxib Value 2021-2025 ($ Millions)

Figure 112. Mexico Celecoxib Consumption 2021-2025 (K Units)

Figure 113. Mexico Celecoxib Value 2021-2025 ($ Millions)

Figure 114. Brazil Celecoxib Consumption 2021-2025 (K Units)

Figure 115. Brazil Celecoxib Value 2021-2025 ($ Millions)

Figure 116. China Celecoxib Consumption 2021-2025 (K Units)

Figure 117. China Celecoxib Value 2021-2025 ($ Millions)

Figure 118. Japan Celecoxib Consumption 2021-2025 (K Units)

Figure 119. Japan Celecoxib Value 2021-2025 ($ Millions)

Figure 120. Korea Celecoxib Consumption 2021-2025 (K Units)

Figure 121. Korea Celecoxib Value 2021-2025 ($ Millions)

Figure 122. Southeast Asia Celecoxib Consumption 2021-2025 (K Units)

Figure 123. Southeast Asia Celecoxib Value 2021-2025 ($ Millions)

Figure 124. India Celecoxib Consumption 2021-2025 (K Units)

Figure 125. India Celecoxib Value 2021-2025 ($ Millions)

Figure 126. Australia Celecoxib Consumption 2021-2025 (K Units)

Figure 127. Australia Celecoxib Value 2021-2025 ($ Millions)

Figure 128. Germany Celecoxib Consumption 2021-2025 (K Units)

Figure 129. Germany Celecoxib Value 2021-2025 ($ Millions)

Figure 130. France Celecoxib Consumption 2021-2025 (K Units)

Figure 131. France Celecoxib Value 2021-2025 ($ Millions)

Figure 132. UK Celecoxib Consumption 2021-2025 (K Units)

Figure 133. UK Celecoxib Value 2021-2025 ($ Millions)

Figure 134. Italy Celecoxib Consumption 2021-2025 (K Units)

Figure 135. Italy Celecoxib Value 2021-2025 ($ Millions)

Figure 136. Russia Celecoxib Consumption 2021-2025 (K Units)

Figure 137. Russia Celecoxib Value 2021-2025 ($ Millions)

Figure 138. Spain Celecoxib Consumption 2021-2025 (K Units)

Figure 139. Spain Celecoxib Value 2021-2025 ($ Millions)

Figure 140. Egypt Celecoxib Consumption 2021-2025 (K Units)

Figure 141. Egypt Celecoxib Value 2021-2025 ($ Millions)

Figure 142. South Africa Celecoxib Consumption 2021-2025 (K Units)

Figure 143. South Africa Celecoxib Value 2021-2025 ($ Millions)

Figure 144. Israel Celecoxib Consumption 2021-2025 (K Units)

Figure 145. Israel Celecoxib Value 2021-2025 ($ Millions)

Figure 146. Turkey Celecoxib Consumption 2021-2025 (K Units)

Figure 147. Turkey Celecoxib Value 2021-2025 ($ Millions)

Figure 148. GCC Countries Celecoxib Consumption 2021-2025 (K Units)

Figure 149. GCC Countries Celecoxib Value 2021-2025 ($ Millions)

Figure 150. Pfizer Inc Celecoxib Market Share (2018-2020)

Figure 151. Teva Celecoxib Market Share (2018-2020)

Figure 152. Apotex Celecoxib Market Share (2018-2020)

Figure 153. Lupin Celecoxib Market Share (2018-2020)

Figure 154. Mylan Celecoxib Market Share (2018-2020)

Figure 155. Hengrui Medicine Celecoxib Market Share (2018-2020)

Sample Request is not available